Jennison Associates LLC Gossamer Bio, Inc. Transaction History

Jennison Associates LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$8.63 - $10.94 $12.6 Million - $15.9 Million	-1,457,886 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$8.3 - $13.59 $155,683 - $254,907	-18,757 Reduced 1.27%	1,457,886 $14.1 Million
Q3 2020 Nov 04, 2020	BUY	$11.3 - $14.75 $60,285 - $78,691	5,335 Added 0.36%	1,476,643 $18.3 Million
Q2 2020 Aug 06, 2020	BUY	$9.52 - $15.98 $7.25 Million - $12.2 Million	761,875 Added 107.39%	1,471,308 $19.1 Million
Q1 2020 May 06, 2020	BUY	$8.0 - $15.48 $833,072 - $1.61 Million	104,134 Added 17.2%	709,433 $7.2 Million
Q3 2019 Nov 08, 2019	SELL	$16.02 - $22.47 $870,046 - $1.22 Million	-54,310 Reduced 8.23%	605,299 $10.2 Million
Q2 2019 Aug 09, 2019	BUY	$16.12 - $22.89 $10.6 Million - $15.1 Million	659,609 New	659,609 $14.6 Million
Q2 2019 Aug 06, 2019	SELL	$16.12 - $22.89 $10.7 Million - $15.1 Million	-661,116 Closed	0 $0
Q1 2019 Aug 13, 2019	BUY	$17.58 - $23.97 $11.6 Million - $15.8 Million	661,116 New	661,116 $14.3 Million

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.